MONO- AND MIXED-HERPESVIRUS INFECTIONS: ASSOCIATION WITH CLINICAL SYNDROMES OF IMMUNODEFICIENCY

Cover Page

Cite item

Full Text

Abstract

In recent years, the number of hard diagnosed, polysymptomatic and polysyndrome conditions and diseases caused by mono- and mixed-herpes infections has sharply increased in the practice of physicians of all specialties. The clinical aspects of the close attention of physicians, virologists and epidemiologists to this viral family are due not only to the onset of atypical forms of these infections, but also to the emergence of the relative new concept of “active chronic atypical infection” caused by herpesviruses and in particular the Epstein-Barr virus. We observed 198 people of both sexes aged between 23 and 60 years, suffering from mono- and mixed herpetic infections (EBV, CMV, HSV 1/2, and HSV type 6). 36% of these, suffered from mono-herpesvirus infections, mixed-herpesvirus infections were diagnosed in 63.7% of cases. A study of functioning characteristics of antiviral protection system as well as defects and disorders in the system of interferons was carried out in patients suffering from various mono-, mixed herpes virus infections and bacterial co-infections. The main clinical syndromes associated with these herpetic infections, as well as prevailing nosological forms of concomitant diseases were revealed. The revealed clinical syndromes and functioning characteristics of an antiviral protection will allow developing of a conceptual, individualized, etio- and immunopathogenetic therapy.

About the authors

I V Nesterova

Kuban Medical Institute

Author for correspondence.
Email: inesterova1@yandex.ru

PhD, MD, Professor of the Kuban Medical Institute

E O Khalturina

Sechenov University

Email: inesterova1@yandex.ru

References

  1. Babcock J.G., Hochberg D., Thorley-Lawson A.D. The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell. Immunity. 2000. 13: 497—506.
  2. Hislop A.D., Taylor G.S., Sauce D., Rickinson A.B. Cellular responses to viral infection in humans: lessons from Epstein-Barr virus. Annu Rev Immunol. 2007. 25, P. 587—617.
  3. Kuzushima K., Matsuoka H. Impaired cytotoxic T lymphocyte response to Epstein-Barr virus-infected NK cells in patients with severe chronic active EBV infection. J Med Virol. 2001.64:141—8.
  4. Lusso P. HHV-6 and the immune system: Mechanisms of immunomodulation and viral escape. J ClinVirol. 2006. 37(Suppl 1):S4—10.
  5. Merlo A., Turrini R., Dolcetti R., Martorelli D., Muraro E., Comoli P., Rosato A. The interplay between Epstein-Barr virus and the immune system: a rationale for adoptive cell therapy of EBV-related disorders. Haematologica. 2010.95(10). P. 1769—1777.
  6. Ning S. Innate immune modulation in EBV infection. Herpesviridae. 2010. 2(1). P. 1.
  7. Pizzigallo Eligio, Racciatti Delia, and Gorgoretti Valeria. EBV Chronic Infections. Mediterr J Hematol Infect Dis. 2010. 2(1).
  8. Randall R.E., Goodbourn S. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J. Gen. Virol. 2008. 89. P. 1—47.
  9. Wu L., Fossum E., Joo C.H., Inn K.S., Shin Y.C., Johannsen E., Hutt-Fletcher L.M., Hass J., Jung J.U. Epstein-Barr virus LF2: an antagonist to type I interferon. J Virol. 2009. 83(2). P. 1140—1146.
  10. Vorobiev A.A., Kiselevskiy M.V., Khalturina E.O. Immune system. Immunology. 2001. № 6. P. 15.
  11. Tracy S.I., Kalacheva K., Lunemann J.D., Luzuiaga K. et al. Persistence of Epstein-Barr virus in self-reactive memory B cells. J. Viorol. 2012. Vol. 88. № 22. P. 12330—12340.
  12. Olson D., Huntington M.K. Co-infections with cytomegalovirus ahd Epstein-Barr virus in mononucleosis: case report and review of literature. S D Med. 2009. V. 62. № 9. P. 351—353.
  13. Xia Wang et al. Coinfection with EBV/CMV and other respiratory agents in children with suspected infectious mononucleosis. Virol. J. 2010. V. 7. P. 247.
  14. Bravender T. Epstein-Barr virus, cytomegalovirus, and infectious mononucleosis. Adolesc. Med. State Art Rev. 2010. V. 21. № 2. P. 251—264.
  15. Ulish Е.I. Persistenceinfectionsandhuman: relationship strategy. Child health. 2009. № 4. P. 114—122.
  16. van de Berg P.J.E.J., Griffiths S.J., Yong, S-L, Macaulay R., Jackson S., Henson S.M., ten Berge I.J.M., Akbar A.N., van Lier A.W. Cytomegalovirus Infection Reduces Telomere. J. Immunol. 2010, 184: 3417—3423.
  17. Poon S.S., Lansdorp P.M. Current Protocols in Cell Biology. 2001. 12:18.4:18.4.1—18.4.21.
  18. Fukumoto H., Kanno T., Hasegawa H., Katano H. Pathology of Kaposi’s sarcoma-associated herpesvirus infection. 2010. Front Microbiol 2: 175.
  19. Kutok J., Wang F. Spectrum of Epstein—Barr virus-associated diseases. Annu Rev Pathol. 2006. P. 375—404.
  20. Levin L., Munger K., O’Reilly E., Falk K., Ascherio A. Primary infection with Epstein-Barr virus and risk of multiple sclerosis. Ann Neurol. 2010. 67: 824—830.

Copyright (c) 2018 Nesterova I.V., Khalturina E.O.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies